Detalhe da pesquisa
1.
Extended Safety and Tolerability of Darolutamide for Nonmetastatic Castration-Resistant Prostate Cancer and Adverse Event Time Course in ARAMIS.
Oncologist
; 2024 Feb 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38394384
2.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
N Engl J Med
; 383(11): 1040-1049, 2020 09 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32905676
3.
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
N Engl J Med
; 380(13): 1235-1246, 2019 03 28.
Artigo
Inglês
| MEDLINE | ID: mdl-30763142
4.
Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS study.
Future Oncol
; 18(40): 4473-4482, 2022 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-36753353
5.
Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial.
Int J Clin Oncol
; 26(3): 578-590, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-33226524
6.
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use.
J Cardiovasc Pharmacol
; 76(1): 4-22, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32639325
7.
Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial.
J Neurol Neurosurg Psychiatry
; 90(10): 1165-1170, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31315908
8.
Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation.
Crit Care
; 19: 67, 2015 Feb 19.
Artigo
Inglês
| MEDLINE | ID: mdl-25887576
9.
Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trial.
Eur J Cancer
; 192: 113258, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37660438
10.
Feasibility and patient acceptability of a commercially available wearable and a smart phone application in identification of motor states in parkinson's disease.
PLOS Digit Health
; 2(4): e0000225, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37027348
11.
Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial.
Eur Urol
; 83(3): 212-221, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36089529
12.
Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials.
JAMA
; 307(11): 1151-60, 2012 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-22436955
13.
Body movement as a biomarker for use in chronic pain rehabilitation: An embedded analysis of an RCT of a virtual reality solution for adults with chronic pain.
Front Pain Res (Lausanne)
; 3: 1085791, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36606032
14.
A prospective, double-blind, pilot, randomized, controlled trial of an "embodied" virtual reality intervention for adults with low back pain.
Pain
; 163(9): 1700-1715, 2022 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35324507
15.
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet Neurol
; 20(10): 821-831, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34536404
16.
Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial.
Eur J Cancer
; 154: 138-146, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34273811
17.
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use.
Card Fail Rev
; 6: e19, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-32714567
18.
Oral levosimendan in patients with severe chronic heart failure --the PERSIST study.
Eur J Heart Fail
; 10(12): 1246-54, 2008 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-18945637
19.
Effect of Sedation Regimen on Weaning from Mechanical Ventilation in the Intensive Care Unit.
Clin Drug Investig
; 38(6): 535-543, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29502195
20.
Erratum to "Efficacy and Safety of Darolutamide in Patients with Nonmetastatic Castration-resistant Prostate Cancer Stratified by Prostate-specific Antigen Doubling Time: Planned Subgroup Analysis of the Phase 3 ARAMIS Trial" [Eur Urol 2022].
Eur Urol
; 83(2): e60, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36526492